Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

News > All

Total search results: 5961 | Ordered by Date (descending)
1 2 3 ... 58 59 60  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Malvern Panalytical B.V.. (1/14/22). "Press Release: Malvern Panalytical Inc. and TA Instruments-Waters LLC Agree to Partial Settlement of Patent Infringement Lawsuit". Almelo. 2022-01-14
Relief Therapeutics Holding AG. (1/14/22). "Press Release: Relief Therapeutics Comments on NRx Pharmaceuticals' Press Release Reporting on its Recently Filed Lawsuit". Geneva. 2022-01-14
Lumicks Technologies B.V.. (1/12/22). "Press Release: Lumicks Announces the Installation of its Quadruple C-Trap® Instrument at Rockefeller University to Expand Fundamental Research of DNA Processes". Amsterdam. 2022-01-12
ProtaGene GmbH. (1/12/22). "Press Release: Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene". Heilbronn, Heidelberg & Boston, MA. 2022-01-12
Relief Therapeutics Holding AG. (1/12/22). "Press Release: Relief Comments on Lawsuit Filed Against It by NeuroRx". Geneva. 2022-01-12
Creoptix AG. (1/11/22). "Press Release: Malvern Panalytical Expands Pharmaceutical Drug Development Solutions through the Acquisition of Creoptix". 2022-01-11
Scitara Corporation. (1/11/22). "Press Release: Scitara Corp. Raises $15m in Series B Financing to Disrupt the Laboratory Data Integration Market". Marlborough, MA. 2022-01-11
Mammoth Biosciences, Inc.. (1/10/22). "Press Release: Bayer and Mammoth Biosciences to Collaborate on Novel Gene Editing Technology". Berlin & Brisbane, CA. 2022-01-10
Electrochaea GmbH. (1/7/22). "Press Release: Growth-Stage Power-to-Gas Company Electrochaea Closes Series D Financing Round". Munich. 2022-01-07
Exscientia plc. (1/7/22). "Press Release: Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines". Paris, Oxford & Boston, MA. 2022-01-07
Novartis AG. (1/6/22). "Press Release: Novartis Announces Collaboration with Alnylam to Explore Targeted Therapy to Restore Liver Function". Basel. 2022-01-06
Merck KGaA. (1/6/22). "Press Release: Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA". Darmstadt. 2022-01-06
Cato SMS. (1/5/22). "Press Release: Cato SMS and Pharm-Olam Merge to Create Global Biopharmaceutical Services Leader". Cary, NC & Bracknell. 2022-01-05
BioNTech SE. (1/5/22). "Press Release: Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine". New York, NY & Mainz. 2022-01-05
ITM Isotope Technologies Munich SE. (1/5/22). "Press Release: ITM Isotope Technologies Munich to Present at the 40th Annual J.P. Morgan Healthcare Conference". Garching. 2022-01-05
T-Knife Therapeutics, Inc.. (1/5/22). "Press Release: T-knife Therapeutics Appoints Ronald Krasnow, J.D., as General Counsel". South San Francisco, CA & Paris. 2022-01-05
PhoreMost Ltd.. (1/5/22). "Press Release: PhoreMost and POLARISqb Announce a Multi-target Collaboration to Investigate Next-generation Cancer Therapies". Cambridge & Durham, NC. 2022-01-05
Spectro Analytical Instruments GmbH. (1/4/22). "Press Release: Change in Spectro Management – Michael Privik Succeeds Dr. Christoph Mätzig". Kleve. 2022-01-04
Bruker Corporation. (1/4/22). "Press Release: Bruker Corporation to Present at the 40th Annual J.P. Morgan Healthcare Conference". Billerica, MA. 2022-01-04
Thermo Fisher Scientific Inc.. (1/4/22). "Press Release: Thermo Fisher Scientific to Present at the 40th Annual J.P. Morgan Healthcare Conference". Waltham, MA. 2022-01-04
Sound Bioventures Management AB. (1/4/22). "Press Release: Sound Bioventures Raises € 110 Million for New Biotherapeutics Venture Fund". Malmö & Copenhagen. 2022-01-04
DNA Script. (1/4/22). "Press Release: DNA Script Closes $200 Million Series C Financing with Completion of Second Tranche". South San Francisco, CA & Paris. 2022-01-04
Noxxon Pharma N.V.. (1/3/22). "Press Release: Noxxon Secures €17 Million Expansion of Equity-linked Facility with Atlas to Advance NOX-A12 in Glioblastoma and Pancreatic Cancer Programs [ corrected version of press release originally issued 29 Dec 2021 ] 2022-01-03
Laboratory Corporation of America Holdings (LabCorp). (12/23/21). "Press Release: Labcorp Strengthens Oncology Leadership Position with the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Produc 2021-12-23
Quidel Corporation. (12/23/21). "Press Release: Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics". San Diego, CA & Raritan, NJ. 2021-12-23
Arix Bioscience plc. (12/22/21). "Press Release: Arix Bioscience Co-leads $31 Million Series A Financing for New Portfolio Company Sorriso Pharmaceuticals". London. 2021-12-22
Sorriso Pharmaceuticals, Inc.. (12/22/21). "Press Release: Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions". Salt Lake City, UT. 2021-12-22
Insightful Science LLC. (12/21/21). "Press Release: Insightful Science Acquires Protein Metrics to Expand its R&D Solution to Include Proteomics". San Diego, CA. 2021-12-21
Sanofi S.A.. (12/21/21). "Press Release: Sanofi to Acquire Amunix Immuno-oncology Pipeline with Next Generation Conditionally Activated Biologics". Paris. 2021-12-21
Argenx SE. (12/20/21). "Press Release: Argenx Announces U.S. Food and Drug Administration (FDA) Approval of Vyvgart (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis". Darmstadt. 2021-12-20
Novartis AG. (12/20/21). "Press Release: Novartis Strengthens Immunotherapy Pipeline with Option, Collaboration and License Agreement with BeiGene for TIGIT inhibitor Ociperlimab". Basel. 2021-12-20
Genenta Science S.p.A.. (12/17/21). "Press Release: Genenta Closes Its Upsized Initial Public Offering of American Depository Shares". Milan & New York, NY. 2021-12-17
NorthSea Therapeutics B.V.. (12/17/21). "Press Release: NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders". Amsterdam. 2021-12-17
Argobio S.A.S.. (12/16/21). "Press Release: Argobio and GeneCode Partner on Parkinson’s Disease in Argobio’s First Announced Research Agreement". Paris & Tallinn. 2021-12-16
Anaveon AG. (12/16/21). "Press Release: Anaveon to Raise CHF 110 Million in Oversubscribed Series B Financing". Basel. 2021-12-16
Evotec SE. (12/16/21). "Press Release: Evotec Receives US$ 18 m Grant for Women’s Health". Hamburg. 2021-12-16
Bico Group AB. (12/16/21). "Press Release: Bico Has Entered into an Agreement to Acquire Biosero, a Leading Software Provider for Automated Workflows and Laboratory Connectivity". 2021-12-16
Agilent Technologies Inc.. (12/15/21). "Press Release: Lonza and Agilent Announce Strategic Collaboration to Integrate New Analytical Technologies with Lonza’s Cocoon Platform". Basel & Santa Clara, CA. 2021-12-15
Depixus S.A.S.. (12/15/21). "Press Release: Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing". Paris & Cambridge. 2021-12-15
Immatics N.V.. (12/14/21). "Press Release: Immatics and Bristol Myers Squibb Enter into Global Exclusive License for Immatics’ TCR Bispecific Program IMA401". Tübingen, Houston, TX & New York, NY. 2021-12-14
Sirius Medical Systems B.V.. (12/14/21). "Press Release: Sirius Medical Announces Second Closing of A-Round Financing". 2021-12-14
Almirall S.A.. (12/14/21). "Press Release: Ichnos Sciences and Almirall Enter into a Licensing Agreement for First-in-Class IL-1RAP Antagonist Monoclonal Antibody". New York, NY & Barcelona. 2021-12-14
Genenta Science S.p.A.. (12/14/21). "Press Release: Genenta Announces Pricing of Upsized Initial Public Offering". Milan & New York, NY. 2021-12-14
Scitara Corporation. (12/14/21). "Press Release: Scitara Corp. Launches New Breakthrough Industry Scientific Integration Platform to Support Laboratory Digital Transformation". Marlborough, MA. 2021-12-14
Mainz Biomed N.V.. (12/14/21). "Press Release: Mainz Biomed Expands ColoAlert Commercialization with Ganzimmun Diagnostics in Europe". Berkeley, CA & Mainz. 2021-12-14
Gilde Healthcare Partners. (12/14/21). "Press Release: Philips Acquires Gilde Portfolio Company Vesper Medical to Further Expand Its Image-guided Therapy Devices Portfolio". Amsterdam & Utrecht. 2021-12-14
Vifor Pharma AG. (12/14/21). "Press Release: CSL Limited Announces Tender Offer to Acquire Vifor Pharma Ltd (ad hoc)". St. Gallen. 2021-12-14
Ryvu Therapeutics S.A.. (12/14/21). "Press Release: Ryvu Announces Option to License Inflammation Program Exercised by Galapagos NV". Tübingen, Houston, TX & New York, NY. 2021-12-14
CellCarta. (12/14/21). "Press Release: CellCarta Acquires Biogazelle to Strengthen Its Genomic Capabilities and Expand into Digital PCR (dPCR) Services". Montréal. 2021-12-14
Pfizer Inc.. (12/13/21). "Press Release: Pfizer to Acquire Arena Pharmaceuticals". New York, NY & Park City, UT. 2021-12-13
Alloy Therapeutics. (12/9/21). "Press Release: Alloy Therapeutics Acquires deepCDR Biologics to Bring Bioinformatics and Machine Learning to its Antibody Discovery Offering". Boston, MA & Basel. 2021-12-09
Eir Ventures Partners AB. (12/9/21). "Press Release: Eir Ventures Closes Life Science Venture Fund at EUR122 million". Stockholm & Copenhagen. 2021-12-09
Anavo Therapeutics B.V.. (12/9/21). "Press Release: Anavo Therapeutics Announces the Appointment of Charles McDermott as Chairman of the Board". Leiden & Heidelberg. 2021-12-09
Forbion Capital Partners. (12/9/21). "Press Release: Forbion European Acquisition Corp. Announces Pricing of $110 Million Initial Public Offering". Naarden. 2021-12-09
Uniqure N.V.. (12/9/21). "Press Release: Uniqure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B". Lexington, MA, Amsterdam & King of Prussia, PA. 2021-12-09
Merck KGaA. (12/8/21). "Press Release: Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million". Darmstadt. 2021-12-08
Wacker Chemie AG. (12/8/21). "Press Release: Aleph Farms and Wacker Develop Open Supply Chain Solution for Proteins Used in Large-Scale Production of Cultivated Meat". Munich & Rehovot. 2021-12-08
Adendra Therapeutics Ltd.. (12/7/21). "Press Release: ATP Launches Adendra Therapeutics, a New Kind of Immunotherapy Company Deploying Novel Insights into Dendritic Cell Biology, with $53M Series A". New York, NY & London. 2021-12-07
Freenome, Inc.. (12/7/21). "Press Release: Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection". South San Francisco, CA. 2021-12-07
Emergence Therapeutics AG. (12/7/21). "Press Release: Emergence Therapeutics Raises €87 Million Series A Financing to Advance Nectin-4 ADC". Duisburg. 2021-12-07
Odyssey Therapeutics. (12/7/21). "Press Release: Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines". Boston, MA. 2021-12-07
Recursion Pharmaceuticals, Inc.. (12/7/21). "Press Release: Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening 2021-12-07
SGS S.A.. (12/7/21). "Press Release: SGS Announces the Acquisition of Quay Pharmaceuticals Limited". 2021-12-07
Recursion Pharmaceuticals, Inc.. (12/6/21). "Press Release: Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities". Salt Lake City, UT. 2021-12-06
Bavarian Nordic A/S. (12/5/21). "Press Release: Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate". Copenhagen. 2021-12-05
Recordati Industria Chimica e Farmaceutica S.p.A.. (12/3/21). "Press Release: Recordati to Acquire EUSA Pharma (UK) Ltd., a Global Specialty Pharmaceutical Company Focused on Rare and Niche Oncology Diseases". Milan. 2021-12-03
UCB S.A.. (12/2/21). "Press Release: UCB Announces Global Partnership to Bring Disease-modifying Therapies to People Living with Parkinson’s Disease". Brussels. 2021-12-02
Fujifilm Diosynth Biotechnologies UK Ltd.. (12/2/21). "Press Release: Fujifilm Diosynth Biotechnologies Confirms £400 Million Investment Plans to Create the Largest Multi-modal Biopharmaceutical Manufacturing Site in the United Kingdom". Billingham. 2021-12-02
SomaLogic, Inc.. (12/2/21). "Press Release: SomaLogic Announces Appointment of Steven Mermelstein as Senior Vice President of Corporate Strategy, Development and Mergers and Acquisitions". Boulder, CO. 2021-12-02
AviadoBio Ltd.. (12/2/21). "Press Release: AviadoBio Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform". London. 2021-12-02
Integra Thepeutics S.L.. (12/2/21). "Press Release: Integra Tx Secures €4.5 Million in Funding from Advent France Biotechnology, Invivo Capital and Takeda Ventures". Barcelona. 2021-12-02
Sotio Biotech a.s.. (12/2/21). "Press Release: Sotio Secures €280m of Funding to Expand and Advance Clinical Pipeline". Prague, Basel & Cambridge, MA. 2021-12-02
Ona Therapeutics. (12/2/21). "Press Release: Ona Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors". Barcelona. 2021-12-02
Roche. (12/1/21). "Press Release: Roche Completes Purchase Agreement with Long-term Partner TIB Molbiol to Expand PCR-test Portfolio in the Fight against New Infectious diseases". Basel. 2021-12-01
Freenome, Inc.. (12/1/21). "Press Release: Freenome Partners with Siemens Healthineers for Breast Cancer Research". South San Francisco, CA. 2021-12-01
ARCH Venture Partners. (12/1/21). "Press Release: ARCH Venture Partners Announces Several Key Appointments". Chicago, IL. 2021-12-01
SciRhom GmbH. (11/30/21). "Press Release: SciRhom Augments Seed Financing to Reach Total Funding of EUR 16 Million". Munich. 2021-11-30
HotSpot Therapeutics, Inc.. (11/29/21). "Press Release: HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic". Boston, MA. 2021-11-29
Ablaze Pharmaceuticals. (11/29/21). "Press Release: Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market". Shanghai & San Diego, CA. 2021-11-29
Blueprint Medicines Corporation. (11/29/21). "Press Release: Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics". Cambridge, MA & San Diego, CA. 2021-11-29
H. Lundbeck A/S. (11/29/21). "Press Release: Lundbeck Announces Changes to Executive Management". Valby. 2021-11-29
Quell Therapeutics Ltd.. (11/29/21). "Press Release: Quell Therapeutics Raises $156 Million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform". London & Boston, 2021-11-29
Orgenesis Inc.. (11/29/21). "Press Release: Orgenesis and Theracell Joint Venture to Receive up to €32 Million From Greek Government to Accelerate Rollout of POCare Centers and Deployment of OMPULs". Germantown, MD. 2021-11-29
SphingoTec GmbH. (11/29/21). "Press Release: SphingoTec Appoints Jörg Menten to Leadership Team as Chief Commercial Officer to Drive New Business Growth". Hennigsdorf. 2021-11-29
Relief Therapeutics Holding AG. (11/24/21). "Press Release: Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product Development Opportunities using Artificial Intelligence". Geneva. 2021-11-24
Centogene N.V.. (11/24/21). "Press Release: Centogene Reports Third Quarter 2021 Financial Results". Cambridge, MA, Rostock & Berlin. 2021-11-24
Trajan Group Holdings Ltd.. (11/24/21). "Press Release: Trajan Acquires Axel Semrau, a Laboratory Automation, Chromatography, and Software Business". 2021-11-24
Relief Therapeutics Holding AG. (11/24/21). "Press Release: Relief Reports that Its U.S. Collaboration Partner Has Announced the U.S. Food and Drug Administration has Denied Breakthrough Designation for Aviptadil". Geneva. 2021-11-24
Allorion Therapeutics Inc.. (11/24/21). "Press Release: Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round". Boston, MA. 2021-11-24
BeiGene, Ltd.. (11/23/21). "Press Release: BeiGene Closes on Property for New U.S. Manufacturing and Clinical R&D Center". Hopewell, NJ, Cambridge, MA & Beijing. 2021-11-23
BeiGene, Ltd.. (11/23/21). "Press Release: BeiGene Announces Approval of Brukinsa (zanubrutinib) in the European Union for Treatment of Adults with Waldenström’s Macroglobulinemia". Basel, Cambridge, MA & Beijing. 2021-11-23
Nykode Therapeutics A/S. (11/23/21). "Press Release: Nykode Therapeutics (formerly Vaccibody*)) Enters into Multi-target License and Collaboration Agreement with Regeneron to Develop Innovative Vaccines against Cancer and Infectious Diseases". Oslo. 2021-11-23
BeiGene, Ltd.. (11/23/21). "Press Release: BeiGene Launches Proposed Initial Public Offering on the STAR Market in China". Cambridge, MA & Beijing. 2021-11-23
Stilla Technologies S.A.S.. (11/23/21). "Press Release: Stilla Technologies Secures Financing of more than €31 Million Adding Casdin Capital and the European Investment Bank to Existing Investors". Paris & Boston, MA. 2021-11-23
Arrowhead Pharmaceuticals Inc.. (11/22/21). "Press Release: Arrowhead Pharmaceuticals Enters Exclusive License Agreement with GSK for ARO-HSD". Pasadena, CA. 2021-11-22
Twist Bioscience Corporation. (11/22/21). "Press Release: Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities". South San Francisco, CA. 2021-11-22
Bruker Corporation. (11/19/21). "Press Release: Bruker Announces Acquisition of Molecubes NV". Ghent. 2021-11-19
Trajan Group Holdings Ltd.. (11/19/21). "Press Release: Trajan Group Acquires Axel Semrau GmbH". 2021-11-19
Dicerna Pharmaceuticals, Inc.. (11/18/21). "Press Release: Novo Nordisk to Acquire Dicerna". Lexington, MA. 2021-11-18
Evotec SE. (11/18/21). "Press Release: Evotec and EQRx Announce Integrated Drug Discovery and Development Partnership". Hamburg & Cambridge, MA. 2021-11-18
1 2 3 ... 58 59 60  next pagenext page



Advertisement

Picture [iito] No Content Marketing 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top